Mechanical Cues Regulating Proangiogenic Potential of Human Mesenchymal Stem Cells through YAP‐Mediated Mechanosensing
- 17 May 2020
- Vol. 16 (25), 2001837-e2001837
- https://doi.org/10.1002/smll.202001837
Abstract
Stem cells secrete trophic factors that induce angiogenesis. These soluble factors are promising candidates for stem cell–based therapies, especially for cardiovascular diseases. Mechanical stimuli and biophysical factors presented in the stem cell microenvironment play important roles in guiding their behaviors. However, the complex interplay and precise role of these cues in directing pro-angiogenic signaling remain unclear. Here, a platform is designed using gelatin methacryloyl hydrogels with tunable rigidity and a dynamic mechanical compression bioreactor to evaluate the influence of matrix rigidity and mechanical stimuli on the secretion of pro-angiogenic factors from human mesenchymal stem cells (hMSCs). Cells cultured in matrices mimicking mechanical elasticity of bone tissues in vivo show elevated secretion of vascular endothelial growth factor (VEGF), one of representative signaling proteins promoting angiogenesis, as well as increased vascularization of human umbilical vein endothelial cells (HUVECs) with a supplement of conditioned media from hMSCs cultured across different conditions. When hMSCs are cultured in matrices stimulated with a range of cyclic compressions, increased VEGF secretion is observed with increasing mechanical strains, which is also in line with the enhanced tubulogenesis of HUVECs. Moreover, it is demonstrated that matrix stiffness and cyclic compression modulate secretion of pro-angiogenic molecules from hMSCs through yes-associated protein activity.Keywords
Funding Information
- National Institutes of Health (U01CA214411, R01GM126571)
- Office of the Secretary of Defense (W911NF‐17‐3‐003)
This publication has 54 references indexed in Scilit:
- Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular DiseaseCell Stem Cell, 2012
- Therapeutic Angiogenesis for Treating Cardiovascular DiseasesTheranostics, 2012
- Synthesis and Characterization of Tunable Poly(Ethylene Glycol): Gelatin Methacrylate Composite HydrogelsTissue Engineering, Part A, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Rebuilding the Damaged Heart: The Potential of Cytokines and Growth Factors in the Treatment of Ischemic Heart DiseaseJournal of the American College of Cardiology, 2010
- Geometric cues for directing the differentiation of mesenchymal stem cellsProceedings of the National Academy of Sciences of the United States of America, 2010
- Preconditioning Promotes Survival and Angiomyogenic Potential of Mesenchymal Stem Cells in the Infarcted Heart via NF-κB SignalingAntioxidants and Redox Signaling, 2010
- Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs)Biochemical and Biophysical Research Communications, 2009
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- The biology of VEGF and its receptorsNature Medicine, 2003